These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10958703)

  • 1. The cost of drug treatment in Ontario.
    Lindberg MC
    Can J Clin Pharmacol; 2000; 7(2):87-9. PubMed ID: 10958703
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on economizing on drug costs].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1982 May; 126(18):824-9. PubMed ID: 7088209
    [No Abstract]   [Full Text] [Related]  

  • 3. A UK national prescribing list?
    Walley T
    Pharmacoeconomics; 1995 Jun; 7(6):471-4. PubMed ID: 10155332
    [No Abstract]   [Full Text] [Related]  

  • 4. Do Rx drugs cost too much? Choices and consequences.
    Pauly M
    Bus Health; 1997 Oct; 15(10):51-2. PubMed ID: 10175195
    [No Abstract]   [Full Text] [Related]  

  • 5. Competitive strategies for drug use.
    McLean W
    Dimens Health Serv; 1990 Nov; 67(8):21-2. PubMed ID: 2276522
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs used in skin outpatient--cost analysis.
    Prakash B; Singh KG; Kishore N
    Indian J Public Health; 1988; 32(3):166-7. PubMed ID: 3271763
    [No Abstract]   [Full Text] [Related]  

  • 7. Specialty pharmaceuticals: developing a management plan.
    Willcutts D
    Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cheapest synonymous preparations--a proposal with unwanted consequences].
    Jacobsen TK
    Tidsskr Nor Laegeforen; 1989 Jun; 109(16):1807-9. PubMed ID: 2749660
    [No Abstract]   [Full Text] [Related]  

  • 9. Affordable medications in India.
    Abraham S
    Fam Pract Manag; 2006 Sep; 13(8):16. PubMed ID: 17022426
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Appropriateness' in Italy: A 'Magic Word' in Pharmaceuticals?
    Garattini L; Padula A
    Appl Health Econ Health Policy; 2017 Feb; 15(1):1-3. PubMed ID: 26987647
    [No Abstract]   [Full Text] [Related]  

  • 11. Substitution--the relevant market.
    Chappell SC
    Med Mark Media; 1981 Sep; 16(9):54, 56. PubMed ID: 10252449
    [No Abstract]   [Full Text] [Related]  

  • 12. Rational drug therapy.
    Benkappa DG
    Indian Pediatr; 1990 May; 27(5):508-10. PubMed ID: 2276784
    [No Abstract]   [Full Text] [Related]  

  • 13. The economics of prescribing.
    Jennings M
    J R Coll Physicians Lond; 1992 Jan; 26(1):66-8. PubMed ID: 1573589
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug cost increases are generated by the 50 top selling pharmaceuticals.
    Health Care Strateg Manage; 2001 Jun; 19(6):14-5, 1. PubMed ID: 11409091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic conservatism: more costly in the long term? A UK perspective.
    Griffin JP
    Pharmacoeconomics; 1995 May; 7(5):378-87. PubMed ID: 10155325
    [No Abstract]   [Full Text] [Related]  

  • 16. Northeast states pursue price controls to stop rise in prescription drug costs.
    Carlson B
    Manag Care; 2000 May; 9(5):12-3. PubMed ID: 11185259
    [No Abstract]   [Full Text] [Related]  

  • 17. These doctor's mission: keeping drug costs down.
    Guglielmo WJ
    Med Econ; 2001 Apr; 78(8):108-10, 113-6. PubMed ID: 11386066
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical price controls at the state level.
    Kozma CM
    Manag Care Interface; 2001 Jul; 14(7):59-60. PubMed ID: 11481818
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rational pharmacotherapy--with a future perspective].
    Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):773. PubMed ID: 19265595
    [No Abstract]   [Full Text] [Related]  

  • 20. Which drugs to prescribe.
    Ebell M
    Fam Pract Manag; 2006 Sep; 13(8):23-4; author reply 24. PubMed ID: 17024760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.